Renal Fanconi syndrome with meropenem-containing regimen in drug-resistant tuberculosis.

Address: Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, UK.; Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK.; These authors contributed equally.; Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium.; Clinical Epidemiology and Medical Statistics Unit, Dept of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy.; World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italy.; Public Health Consulting Group, Lugano, Switzerland.; University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.; World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italy [email protected].